323 related articles for article (PubMed ID: 31415975)
1. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
[TBL] [Abstract][Full Text] [Related]
2. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
3. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
[TBL] [Abstract][Full Text] [Related]
4. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
5. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
[TBL] [Abstract][Full Text] [Related]
7. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
8. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
9. Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.
Wang Y; Zhang Y; Zhang J; Lu J; Yang C; Zhao J; Li G; Liu Z; Lei Y
Stem Cell Res; 2017 Dec; 25():22-25. PubMed ID: 29035843
[TBL] [Abstract][Full Text] [Related]
10. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
11. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
[TBL] [Abstract][Full Text] [Related]
12. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.
Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG
Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143
[TBL] [Abstract][Full Text] [Related]
13. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
14. Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling.
Sivapatham R; Zeng X
Methods Mol Biol; 2016; 1353():25-44. PubMed ID: 25520284
[TBL] [Abstract][Full Text] [Related]
15. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells (iPSCs) derived from frontotemporal dementia patient's peripheral blood mononuclear cells.
Lee HK; Morin P; Wells J; Hanlon EB; Xia W
Stem Cell Res; 2015 Sep; 15(2):325-7. PubMed ID: 26246272
[TBL] [Abstract][Full Text] [Related]
17. Generation of four iPSC lines from Neurofibromatosis Type 1 patients.
Bozaoglu K; Shern Lee W; Haebich KM; North KN; Payne JM; Lockhart PJ
Stem Cell Res; 2020 Dec; 49():102013. PubMed ID: 33091851
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.
Wen W; Zhang JP; Xu J; Su RJ; Neises A; Ji GZ; Yuan W; Cheng T; Zhang XB
Stem Cell Reports; 2016 Jun; 6(6):873-884. PubMed ID: 27161365
[TBL] [Abstract][Full Text] [Related]
19. Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus.
Soares FA; Pedersen RA; Vallier L
Methods Mol Biol; 2016; 1357():23-31. PubMed ID: 25687300
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
